Skip to main content
. 2014 May 12;19(5):6031–6046. doi: 10.3390/molecules19056031

Table 3.

Percentages of alive, early apoptotic, late apoptotic and necrotic A-549 cells after treatments with [3](CF3SO3)4 and [8](CF3SO3)4 or without compounds (control).

Compound Living cells (%) Early apoptotic (%) Late apoptotic (%) Necrotic (%) Total apoptotic cells (%)
Control 78.37 0.84 6.18 14.61 7.02
[3](CF3SO3)4 60.40 4.73 23.30 11.57 28.03
[8](CF3SO3)4 62.46 1.58 13.04 22.92 14.62